A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Blood Cancer Journal, Published online: 01 October 2019; doi:10.1038/s41408-019-0240-6A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

http://feeds.nature.com/~r/bcj/rss/current/~3/9ggDcHHTUQM/s41408-019-0240-6

Source: Blood Cancer Journal - September 30, 2019 Category: Hematology Authors: Hans C. Lee Jatin J. Shah Lei Feng Elisabet E. Manasanch Rebecca Lu Ashley Morphey Brandon Crumpton Krina K. Patel Michael L. Wang Raymond Alexanian Sheeba K. Thomas Donna M. Weber Robert Z. Orlowski Source Type: research